Sanofi

CIK 0001121404 · Q1 2026

13F Equity AUM

$336.0M

+8.2% QoQ

Positions

+1 QoQ

AUM Rank

#5,516

Top 44%

Skill Alpha (FF)

—

Building track record (4q)

Quarters Tracked

~1 years

Portfolio Concentration

Top 5: 89.0%Top 10: 100.0%Top 20: 100.0%

MGTX31.4%

INBX23.2%

NVV116.7%

ANAB9.0%

Agomab Therapeutics NV8.7%

MPLT5.5%

IMRX4.3%

ELDN0.8%

QTTB0.5%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare91.3%

Unclassified8.7%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 9Median: 8.69%Avg: 11.11%

0–0.5%

1(0.5%)

0.5–1%

1(0.8%)

1–3%

0(0.0%)

3–5%

1(4.3%)

5%+

6(94.5%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 8Unique: 1vs 20 funds

0.1%Low

Fund positions

7,299

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Most Similar Funds

Top 8 benchmark funds with highest portfolio overlap (Jaccard similarity)

BlackRock, Inc.

0.2%

GEODE CAPITAL MANAGEMENT, LLC

0.2%

VANGUARD CAPITAL MANAGEMENT LLC

0.2%

STATE STREET CORP

0.2%

VANGUARD PORTFOLIO MANAGEMENT LLC

0.2%

FMR LLC

0.2%

BANK OF AMERICA CORP /DE/

0.1%

MORGAN STANLEY

0.1%

Jaccard similarity per fund: shared CUSIPs / (fund A + fund B − shared). Higher values indicate more similar portfolios.

Loading overlap analysis...

Position Changes This Quarter

New1Increased0Decreased0Exited0

New Positions

Agomab Therapeutics …8.7%

+2.8M

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...